OMDM-6
OMDM-6 is a hybrid agonist of vanilloid receptor type 1 (VR1, TRPV1) (EC50=75 nM) and cannabinoid receptor type 1 (CB1) (Ki=3.2 μM) . OMDM-6 inhibits anandamide cellular uptake (ACU) with a Ki of 7.0 μM[1].
Product Specifications
CAS Number
616884-67-4
UNSPSC
12352005
Target
Cannabinoid Receptor; Endogenous Metabolite; TRP Channel
Type
Reference compound
Related Pathways
GPCR/G Protein; Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/omdm-6.html
Concentration
10mM
Solubility
10 mM in DMSO
Smiles
CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(NNCC1=CC=C(O)C(OC)=C1)=O
Molecular Formula
C28H42N2O3
Molecular Weight
454.64
References & Citations
[1]Ortar G, et al. Novel selective and metabolically stable inhibitors of anandamide cellular uptake. Biochem Pharmacol. 2003 May 1;65 (9) :1473-81.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
